Literature DB >> 27911431

[. Oсumethyl in the treatment of allergic diseases of eyelids and conjunctiva].

N R Marchenko1.   

Abstract

Treatment of allergic diseases of eyelids and conjunctiva (conjunctivites and blepharoconjunctivites) often presents difficulties due to peculiarities of their pathogenesis - allergic and vascular reactions, disorder of lacrimal production, meibomian gland dysfunction, and possible bacterial contamination. It has been suggested to use Ocumethyl, which contains zinc sulfate (binding, drying, anti-inflammatory, and antiseptic effect), diphenhydamine hydrochloride (an Н1-antihistamine that decreases capillary permeability and helps resolve conjunctival and eyelid edema), naphazoline hydrochloride (a sympathomimetic notable for its strong, rapid, and long-lasting vasoconstrictive effect), and methylene blue (antiseptic effect, disintoxication, and antioxidant activity). A total of 80 patients with chronic allergic conjunctivitis, blepharoconjuntivitis, or giant papillary conjunctivitis associated with contact lens wearing were treated with Ocumethyl instillations (3 times daily for 15-30 days). A clinically significant effect was obtained in 77-91% of patients depending on the disease entity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27911431     DOI: 10.17116/oftalma2016132581-85

Source DB:  PubMed          Journal:  Vestn Oftalmol        ISSN: 0042-465X


  1 in total

1.  Methylene Blue Inhibits Acute Hemorrhagic Conjunctivitis Virus Production and Induction of Caspase-3 Mediated Human Corneal Cell Cytopathy.

Authors:  Marlyn P Langford; Alexandra R Sebren; Maxwell A Burch; Thomas B Redens
Journal:  Clin Ophthalmol       Date:  2020-12-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.